No Increased Risk of Posttransplant Lymphoproliferative Disorder Following Alemtuzumab Induction in Kidney Transplant Article (Web of Science)

cited authors

  • Oliver, Madeleine; Mitro, Graham; Tenbrink, Patrick; Alharthi, Samer; Bedford, Nastassja; Wu, Jinling; Gohara, Amira; Jordan, Matthew; Zaremba, Cassandra; Rees, Michael; Ortiz, Jorge

publication date

  • June 1, 2019

webpage

category

keywords

  • Campath
  • Kidney transplant outcomes
  • Transplantation

start page

  • 320

end page

  • 325

volume

  • 17

issue

  • 3